Get started
Author

Natacha Naoun

Observed names: N. Naoun, Naoun, Natacha
ORCID: 0000-0001-7162-6869
Observed ORCID: 0000-0001-7162-6869
OpenAlex ID: A5071940868
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
2024 · Ronan Flippot, Marcus Teixeira, et al. · Journal for ImmunoTherapy of Cancer · 41
PDF
Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National Survey
2020 · Marc Hilmi, Alice Boilève, et al. · JCO Global Oncology · 41
PDF
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
2023 · Clara Helal, Cédric Pobel, et al. · European Journal of Cancer · 25
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2023 · Naoual Menssouri, Loïc Poiraudeau, et al. · Clinical Cancer Research · 23
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer
2022 · Ronan Flippot, Anna Patrikidou, et al. · Drugs · 22
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial
2024 · Karim Fizazi, Gwénaël Le Teuff, et al. · Journal of Clinical Oncology · 19
The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and Pitfalls
2022 · Thibaut Pierre, Fatine Selhane, et al. · Cancers · 13
PDF
Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary survey
2020 · Marc Hilmi, Anna Pellat, et al. · BMJ Supportive & Palliative Care · 11
Androgen receptor (AR) mutations in men with metastatic castration-resistant prostate cancer (mCRPC): Incidence and natural history.
2023 · Alice Bernard-Tessier, Guillaume Mulier, et al. · Journal of Clinical Oncology · 10
Objectifs, motivations et difficultés des internes en phase socle en oncologie
2021 · Marc Hilmi, Elisabeth Ashton, et al. · Bulletin du Cancer · 10
PDF
Guide sur le rôle du « Docteur Junior » en oncologie médicale
2021 · Adrien Rousseau, Elisabeth Ashton, et al. · Bulletin du Cancer · 10
PDF
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer
2023 · Luca Antonelli, Davide Ardizzone, et al. · Journal of Clinical Oncology · 9
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
2023 · Luca Antonelli, Davide Ardizzone, et al. · European Journal of Cancer · 9
PDF
The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond
2025 · Alice Bernard-Tessier, Natacha Naoun, et al. · Therapeutic Advances in Medical Oncology · 8
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
2023 · Ludovic Bigot, Jonathan Sabio, et al. · European Urology Oncology · 7
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)
2025 · Javier Gavira, Edouard Auclin, et al. · European Journal of Cancer · 6
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
2024 · Ronan Flippot, Tugce Telli, et al. · European Urology Oncology · 6
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study
2023 · Edwige Baudry, Natacha Naoun, et al. · European Journal of Cancer · 4
Stage II Seminoma: Why Chemotherapy Should Remain a Standard
2023 · Natacha Naoun, Alice Bernard-Tessier, et al. · European Urology Open Science · 4
1452MO Longitudinal analysis reveals gut microbiota shift during standard therapies in metastatic renal cell carcinoma (mRCC)
2022 · C. Alves Costa Silva, G. Piccinno, et al. · Annals of Oncology · 4
État des lieux de la formation initiale de l’internat d’oncologie après la quatrième vague pandémie de la COVID-19 : une enquête AERIO-SFJRO
2022 · Adrien Rousseau, Quentin Laune, et al. · Bulletin du Cancer · 4
SARS-CoV-2 et cancer en France : les internes d’oncologie en première ligne. Témoignage des internes d’oncologie de deux clusters français : le Grand-Est et l’Île-de-France
2020 · Matthieu Delaye, Natacha Naoun, et al. · Bulletin du Cancer · 4
ODM-209, a CYP 11A1 inhibitor in patients with mCRPC: Results from the STESIDES phase 1 study.
2024 · Alice Bernard-Tessier, Iben Spanggaard, et al. · Journal of Clinical Oncology · 3
PDF
Systemic treatment among frail older patients with cancer: An observational cohort
2024 · Solène Doublet, Arnaud Pagès, et al. · Journal of Geriatric Oncology · 2
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study
2022 · Marc Hilmi, Natacha Naoun, et al. · Supportive Care in Cancer · 2
Works count: 207
Citation count: 311
H-index: 10
I10-index: 11
Year
Topic
Type